Saturday, November 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Newell Brands Shares Plummet Following Disappointing Earnings Report

Robert Sasse by Robert Sasse
November 3, 2025
in Analysis, Consumer & Luxury, Earnings
0
Newell Brands Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

The consumer goods sector is undergoing a significant transformation, and Newell Brands finds itself at the center of this challenging period. The company’s stock reached unprecedented lows after the release of disappointing quarterly results that fell far below market expectations.

Third Quarter Performance Reveals Substantial Challenges

For the third quarter of 2025, reported on October 31, Newell Brands disclosed a 7.2% decline in net sales, which fell to $1.806 billion. The company’s core sales experienced an even steeper contraction, dropping by 7.4%. This performance was primarily driven by three key factors: reduced retail inventory levels, international market difficulties—with particular weakness in Brazil—and diminished consumer response to tariff-related price increases.

Despite these revenue challenges, the company managed to post a profit of $21 million, marking an improvement from the loss recorded during the same period in the previous year. However, this positive development was tempered by a contraction in gross margin, which settled at 34.1%. This margin pressure stemmed from tariff expenses, volume reductions, and inflationary pressures. Notably, excluding one-time China tariffs totaling $24 million, the company’s margin would have shown modest expansion.

Revised Outlook Intensifies Investor Concerns

Market sentiment deteriorated further when management substantially lowered its full-year guidance. The company now anticipates earnings per share in the range of $0.56 to $0.60, signaling that current headwinds are expected to persist throughout the coming months. A significant factor impacting this outlook is the projected tariff costs of approximately $180 million for the full year, which will continue to exert pressure on profitability.

Should investors sell immediately? Or is it worth buying Newell Brands?

The market response to these developments was immediate and severe. Newell Brands’ equity value declined by approximately 28% following the announcement, establishing new record lows. Since the beginning of the year, the stock has surrendered more than two-thirds of its value, creating substantial losses for shareholders.

Navigating Multiple Operational Challenges

Newell Brands currently confronts several simultaneous operational hurdles. Management cited “significant trade disruptions” resulting from tariffs, a challenging consumer spending environment, and persistent international weaknesses as creating substantial pressure on business operations. While the quarterly profit provided some relief to the company’s balance sheet, underlying structural issues remain unaddressed.

The critical question facing investors is whether this consumer goods conglomerate can reverse its downward trajectory. Current financial results and the reduced guidance offer limited optimism for a near-term recovery. As the entire industry undergoes transformation, Newell Brands faces one of the most significant tests in its recent corporate history.

Ad

Newell Brands Stock: Buy or Sell?! New Newell Brands Analysis from November 8 delivers the answer:

The latest Newell Brands figures speak for themselves: Urgent action needed for Newell Brands investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 8.

Newell Brands: Buy or sell? Read more here...

Tags: Newell Brands
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Emergent BioSolutions Stock
Earnings

Can Emergent BioSolutions Stock Maintain Its Upward Trajectory?

November 8, 2025
Trinity Biotech Stock
Analysis

Trinity Biotech Shares Face Persistent Downward Pressure

November 8, 2025
I-Mab Stock
Analysis

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

November 8, 2025
Next Post
Kura Oncology Stock

Pivotal Week Ahead for Kura Oncology Investors

Wabtec Stock

Wabtec Shares Poised for Growth on Strong Quarterly Performance

Natera Stock

Natera Shares Approach Critical Earnings Test

Recommended

Food Retailers Market Capitalization

PVH Corps Short Interest Sees Significant Drop

2 years ago
Fiances and technology

Rising Interest in Cybersecurity Stocks in 2024

2 years ago
Global X NASDAQ 100 Covered Call ETF Stock

Generating Steady Returns with the Nasdaq 100 Covered Call Approach

1 month ago
Conagra Brands Stock

Key Financial Executive Departs Conagra Brands Ahead of Earnings

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

US Energy’s Pivotal Moment: Navigating Financial Headwinds with Ambitious Strategy

A Critical Year Ahead for Minerva Neurosciences

Scynexis at a Crossroads: Can a GSK Deal Reverse Its Fortunes?

Redcare Pharmacy Shares Plunge Despite Strong Fundamentals

Quantum Computing Stock Plummets Amidst Financial Turmoil

Trending

Intevac Stock
Mergers & Acquisitions

Intevac Acquisition Finalized as Seagate Completes Takeover

by Andreas Sommer
November 8, 2025
0

The corporate journey of Intevac reached its conclusion in early 2025 when Seagate Technology successfully acquired the...

Emergent BioSolutions Stock

Can Emergent BioSolutions Stock Maintain Its Upward Trajectory?

November 8, 2025
Trinity Biotech Stock

Trinity Biotech Shares Face Persistent Downward Pressure

November 8, 2025
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

November 8, 2025
US Energy Stock

US Energy’s Pivotal Moment: Navigating Financial Headwinds with Ambitious Strategy

November 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Intevac Acquisition Finalized as Seagate Completes Takeover
  • Can Emergent BioSolutions Stock Maintain Its Upward Trajectory?
  • Trinity Biotech Shares Face Persistent Downward Pressure

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com